Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Avanee Ketkar"'
Autor:
Natella I. Enukashvily, Nikita V. Ponomartsev, Avanee Ketkar, Roman Suezov, Anna V. Chubar, Andrey D. Prjibelski, Daria D. Shafranskaya, Sabrina Elmshäuser, Corinna U. Keber, Vera N. Stefanova, Andrey L. Akopov, Ursula Klingmüller, Petra I. Pfefferle, Thorsten Stiewe, Matthias Lauth, Anna I. Brichkina
Publikováno v:
Cell Death and Disease, Vol 14, Iss 1, Pp 1-15 (2023)
Abstract The abnormal tumor microenvironment (TME) often dictates the therapeutic response of cancer to chemo- and immuno-therapy. Aberrant expression of pericentromeric satellite repeats has been reported for epithelial cancers, including lung cance
Externí odkaz:
https://doaj.org/article/37e5b9bbd3824838a0df904eaa43bbc0
EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs)
Autor:
Marco Schiavo Lena, Ilaria Marinoni, Stefano Partelli, Valentina Andreasi, Corina Kim-Fuchs, Renaud Maire, Annunziata Di Domenico, Simon Leonhard April-Monn, Massimo Falconi, Jörg Schrader, Aurel Perren, Claudio Doglioni, Francesca Muffatti, Avanee Ketkar, Martin Carl Sadowski, Michelle Buri
Publikováno v:
Cancers, Vol 13, Iss 5014, p 5014 (2021)
April-Monn, Simon Leonhard; Andreasi, Valentina; Schiavo Lena, Marco; Sadowski, Martin Carl; Kim-Fuchs, Corina; Buri, Michelle Claudine; Ketkar, Avanee; Maire, Renaud; Di Domenico, Annunziata; Schrader, Jörg; Muffatti, Francesca; Doglioni, Claudio; Partelli, Stefano; Falconi, Massimo; Perren, Aurel; Marinoni, Ilaria (2021). EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs). Cancers, 13(19) MDPI AG 10.3390/cancers13195014
Cancers
Volume 13
Issue 19
April-Monn, Simon Leonhard; Andreasi, Valentina; Schiavo Lena, Marco; Sadowski, Martin Carl; Kim-Fuchs, Corina; Buri, Michelle Claudine; Ketkar, Avanee; Maire, Renaud; Di Domenico, Annunziata; Schrader, Jörg; Muffatti, Francesca; Doglioni, Claudio; Partelli, Stefano; Falconi, Massimo; Perren, Aurel; Marinoni, Ilaria (2021). EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs). Cancers, 13(19) MDPI AG 10.3390/cancers13195014
Cancers
Volume 13
Issue 19
Pancreatic neuroendocrine neoplasms are epigenetically driven tumors, but therapies against underlying epigenetic drivers are currently not available in the clinical practice. We aimed to investigate EZH2 (Enhancer of Zest homolog) expression in PanN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f76f4ae7aa4bf6cbe1fa068a037de20
https://www.mdpi.com/2072-6694/13/19/5014
https://www.mdpi.com/2072-6694/13/19/5014
Autor:
A.M. Brzozowska, Timofei S. Zatsepin, Hooi Hong Lau, Hui Mun Loh, Mitali Kakran, Avanee Ketkar, Anna Brichkina, Daria B. Trushina, Tatiana O. Abakumova, Marina V. Novoselova, Maria N. Antipina, Dmitry A. Gorin
Publikováno v:
ACS applied materialsinterfaces. 12(5)
Formulated forms of cancer therapeutics enhance the efficacy of treatment by more precise targeting, increased bioavailability of drugs, and an aptitude of some delivery systems to overcome multiple drug resistance of tumors. Drug carriers acquire im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e630b8fcc5156398a8da1b5eac8c619
https://pubmed.ncbi.nlm.nih.gov/31942802
https://pubmed.ncbi.nlm.nih.gov/31942802